Status:
COMPLETED
HIV Self Testing of Male Partners of Women in PMTCT
Lead Sponsor:
University of Washington
Collaborating Sponsors:
National Institute of Mental Health (NIMH)
Harvard University
Conditions:
ART Adherence
PMTCT
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The investigators will conduct a randomized trial to evaluate whether provision of oral HIV self-test kits (HIVST) to HIV-positive pregnant women to provide to their male partner, increases the propor...
Detailed Description
Uganda has the fifth highest HIV burden globally and one of the highest fertility rates in Africa. Prevention of mother-to-child HIV transmission Option B+ (PMTCT B+) is national policy in Uganda. To ...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Eligibility
- For all participants
- Able and willing to provide written informed consent
- Able and willing to provide adequate locator information for study retention purposes
- For women
- Age ≥18
- Currently pregnant
- HIV-positive based on positive rapid HIV tests, according to national algorithm
- Not currently enrolled in an HIV treatment study
- Male partner not known to be HIV-positive or has not tested in the past 3 months
- For men - In partnership with an HIV-positive pregnant woman in PMTCT B+
- Exclusion criteria:
- \- None
Exclusion
Key Trial Info
Start Date :
May 17 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 22 2021
Estimated Enrollment :
736 Patients enrolled
Trial Details
Trial ID
NCT03484533
Start Date
May 17 2018
End Date
November 22 2021
Last Update
March 27 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Infectious Disease Institute
Kampala, Uganda